Innospec (NASDAQ:IOSP) Stock Rating Lowered by Wall Street Zen

Innospec (NASDAQ:IOSP) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Sunday.

A number of other research firms have also recently commented on IOSP. Zacks Research upgraded Innospec from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Weiss Ratings upgraded Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Innospec has a consensus rating of “Moderate Buy”.

Innospec Stock Up 0.4%

NASDAQ:IOSP opened at $74.39 on Friday. Innospec has a 52 week low of $73.58 and a 52 week high of $128.35. The stock has a market capitalization of $1.85 billion, a PE ratio of 95.37 and a beta of 1.04. The stock’s 50-day moving average price is $81.18 and its 200-day moving average price is $84.46.

Innospec (NASDAQ:IOSP) last posted its earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.09. Innospec had a return on equity of 10.89% and a net margin of 1.08%.The firm had revenue of $439.70 million for the quarter, compared to analysts’ expectations of $440.70 million. During the same period last year, the firm earned $1.39 EPS. The company’s quarterly revenue was up 1.1% on a year-over-year basis. Sell-side analysts expect that Innospec will post 6.18 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in Innospec in the 2nd quarter worth approximately $28,000. Tsfg LLC purchased a new position in Innospec in the 1st quarter worth approximately $35,000. EverSource Wealth Advisors LLC lifted its stake in Innospec by 1,159.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock worth $44,000 after purchasing an additional 487 shares in the last quarter. Blue Trust Inc. lifted its stake in Innospec by 38.3% in the 2nd quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company’s stock worth $57,000 after purchasing an additional 186 shares in the last quarter. Finally, State of Wyoming lifted its stake in Innospec by 27.5% in the 2nd quarter. State of Wyoming now owns 801 shares of the specialty chemicals company’s stock worth $67,000 after purchasing an additional 173 shares in the last quarter. 96.64% of the stock is owned by hedge funds and other institutional investors.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.